Determinants of developing diabetes mellitus and vascular complications in patients with impaired fasting glucose
- PMID: 24083174
- PMCID: PMC3784876
- DOI: 10.4103/2230-8210.117240
Determinants of developing diabetes mellitus and vascular complications in patients with impaired fasting glucose
Abstract
Aims: To detect the risk factors of diabetes mellitus (DM) and cardiovascular complications in subjects with impaired fasting glucose (IFG).
Materials and methods: One hundred and twenty three subjects with proved IFG in Zanjan Healthy Heart Study (2002-2003) were recalled and participated in this study (2009-2010). Demographic and laboratoryinformation of the participants were collected.Ischemic heart disease (IHD) was assessed by the exercise tolerance test (ETT). All the subjects with abnormal ETT or documented past history of IHD confirmed by angiographic evaluation. Ophthalmic complications including cataract, glaucoma, and diabetic retinopathy were estimated by an ophthalmologist.
Results: Incidence of DM was 19.5%. All the diabetic and pre-diabetic patients had at least one of the other components of metabolic syndrome. Obesity (P: 0.04, OR: 1.8, 95%CI: 1.2-9) and low physical activity (P < 0.001, OR: 9.6, 95%CI: 3.4-32) were the only independent prognostic risk factors for progression to DM in patients with IFG. Total incidence of IHD was 14.6% and had a strong correlation with sex (P: 0.01, OR: 1.8, 95%CI: 1.2-1.5), age (P < 0.001, OR: 23, 95%CI: 2.1-67) and cigarette smoking (P < 0.001, OR: 36.5, 95%CI: 3.9-337). Non-proliferative diabetic retinopathy was shown in 2 (1.6%) subjects who were all women.
Conclusion: Obesity and low physical activity are the main factors of developing DM and its macrovascular complications in subjects with IFG.
Keywords: Diabetes mellitus; impaired fasting glucose; ischemic heart disease; metabolic syndrome; retinopathy.
Conflict of interest statement
References
-
- Weiss R. Impaired glucose tolerance and risk factors for progression to type 2 diabetes in youth. Pediatr Diabetes. 2007;8:70–5. - PubMed
-
- Muhlestein JB, Anderson JL, Horne BD, Lavasani F, Allen Maycock CA, Bair TL, et al. Effect of fasting glucose levels on mortality rate in patients with and without diabetes mellitus and coronary artery disease undergoing percutaneous coronary intervention. Am Heart J. 2003;146:351–8. - PubMed
-
- Iribarren C, Go AS, Husson G, Sidney S, Fair JM, Quertermous T, et al. Metabolic syndrome and early-onset coronary artery disease: Is the whole greater than its parts? J Am Coll Cardiol. 2006;48:1800–7. - PubMed
-
- Koro CE, Bowlin SJ, Rabatin V, Fedder DO. Cardiovascular disease risk among subjects with impaired fasting glucose in the United States, Results from NHANES 1999-2004 United States. Diabetes and Metabolic Syndrome: Clinical Research and Reviews. 2008;2:239–44.
-
- Liu J, Grundy SM, Wang W, Smith SC, Jr, Vega GL, Wu Z, et al. Ten-year risk of cardiovascular incidence related to diabetes, prediabetes, and the metabolic syndrome. Am Heart J. 2007;153:552–8. - PubMed
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous